NCT06208137

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation, a Prospective, Multicenter, Randomized Controlled Study.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 456 (estimated)
• Sponsor: Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

To assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.

Detailed description

This study aims to prospectively evaluate the effectiveness of the Composite Immune Risk Score in real-world clinical setting.

Conditions

• Transplant-Related Disorder

Interventions

Type	Name	Description
BEHAVIORAL	Health monitoring and regular return follow-up reminders	Health monitoring \& reminders for blood tests and follow-up visits until 1 year post-transplant

Timeline

• Start date: 2024-02-29
• Primary completion: 2027-10-01
• Completion: 2028-04-01
• First posted: 2024-01-17
• Last updated: 2024-08-13

Locations

1 site across 1 country: China